Why invest in weight loss drugs Understanding market trends is crucial for those looking into how to invest in weight loss drugs
In response to comments that our proposed approach risks circular and destabilizing effects across both FFS and MA and could create uncertainty within the MA program, FFS program, and value-based payment models that depend on a stable FFS baseline, we disagree
Application of Next-Generation sequencing following tandem mass spectrometry to expand newborn screening for inborn errors of metabolism: A multicenter study
GLP-1 (NASH) GLP-1
Advanced considerations Combining retatrutide with other peptides Retatrutide covers the GLP-1, GIP, and glucagon receptor pathways comprehensively
- March 5, 2026 - AM-PR In conjunction with Obesity Care Week, a national survey from Phenomix Sciences among medication-experienced patients found that GLP-1 outcomes, tolerability, and downstream care needs vary widely, reinforcing the need for more individualized obesity care
